Archives
- Interim Close: HMRC approved Human Health EIS Knowledge Intensive Fund 23 October, 2021
- o2h Ventures “Human Health SEIS Fund” Invests into Sanome… 7 October, 2021
- o2h Ventures Human Health Tax Efficient Investment Funds 30 September, 2021
- o2h Ventures portfolio company Small Pharma Successfully Completes Phase I Clinical Trial of DMT-assisted therapy 22 September, 2021
- o2h group is supporting the upcoming BiotechBikers’ networking event in The UK 16 September, 2021
- o2h Ventures backed Arecor enters into an exclusive formulation collaboration with Intas Pharmaceuticals 8 September, 2021
- o2h Ventures makes it to the finals in the EISA Awards 2021… 31 August, 2021
- o2h Ventures backed In4Derm enters into an exclusive license agreement with VYNE Therapeutics 13 August, 2021
- o2h Ventures ‘Knowledge Intensive Human Health EIS Fund’ invests into BiVictriX Therapeutics 5 August, 2021
invest in the growth potential of UK life science & AI